Molecular abnormalities associated with secretory carcinomas of the breast

Human Pathology

Volumn 30, Issue 12, 1999, Pages 1435-1440

  Maitra, Anirban ^b   Tavassoli, Fattaneh A ^b   Albores Saavedra, Jorge ^b   Behrens, Carmen ^b   Wistuba, Ignacio I ^b   Bryant, David ^b   Weinberg, Arthur G ^b   Rogers, Beverly B ^b   Saboorian, M Hossein ^b   Gazdar, Adi F ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b NONE

Author keywords

Infiltrating ductal carcinomas; Loss of heterozygosity; p53 mutation; Secretory carcinomas

Indexed keywords

BRCA1 PROTEIN; PROTEIN P53;

ADULT; ARTICLE; BREAST CARCINOMA; CHILD; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 3P; CHROMOSOME 8P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MALE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 12944335244     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90165-X     Document Type: Article

References (20)

1. McDivitt RW, Stewart FW: Breast carcinoma in children. JAMA 195:388-390, 1966
2. Tavassoli FA, Norris HJ: Secretory carcinoma of the breast. Cancer 45:2404-2413, 1980
3. Rosen PP, Cranor ML: Secretory carcinoma of the breast. Arch Pathol Lab Med 115:141-144, 1991
4. Tavassoli FA: Secretory carcinoma, in Tavassoli FA (ed): Pathology of the Breast. Norwalk, CT, Appleton & Lange, 1992, pp 384-390
5. Krausz T, Jenkins D, Grontoft O, et al: Secretory carcinoma of the breast in adults: Emphasis on late recurrence and metastasis. Histopathology 14:25-36, 1989
6. Botta G, Fessia L, Ghiringhello B: Juvenile milk protein secreting carcinoma. Virchows Arch [Pathol Anat] 395:145-152, 1982
7. Tokunaga M, Wakimoto J, Muramoto Y, et al: Juvenile secretory carcinoma and juvenile papillomatosis. Jpn J Clin Oncol 15:457-465, 1985
8. DeMichele A, Weber BL: Recent advances in breast cancer biology. Curr Opin Oncol 9:499-504, 1997
9. Bonner RF, Emmert-Buck M, Cole K, et al: Laser capture microdissection: Molecular analysis of tissue. Science 278:1481, 1483, 1997
10. Wistuba II, Montellano FD, Milchgrub S, et al: Deletions of chromosome 3p are frequent and early events in the pathogenesis of uterine cervical carcinoma. Cancer Res 57:3154-3158, 1997
11. Wistuba II, Behrens C, Milchgrub S, et al: Comparison of molecular changes in lung cancers in HIV-positive and HIV-indeterminate subjects. JAMA 279:1554-1559, 1998
12. Wistuba II, Behrens C, Milchgrub S, et al: Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 18:643-650, 1999
13. Richard G, Hawk JCD, Baker AS Jr, et al: Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature. J Surg Oncol 44:238-244, 1990
14. Wistuba II, Behrens C, Virmani AK, et al: Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. Cancer Res 59:1973-1979, 1999
15. Kinoshita T, Ueda M, Enomoto K, et al: Comparison of p53 gene abnormalities in bilateral and unilateral breast cancer. Cancer 76:2504-2509, 1995
16. Saitoh S, Cunningham J, De Vries EM, et al: p53 gene mutations in breast cancers in midwestern US women: Null as well as missense-type mutations are associated with poor prognosis. Oncogene 9:2869-2875, 1994
17. Tamura G, Kaizuka H, Iwasaki T, et al: [Non-invasive secretory carcinoma of the breast]. Gan No Rinsho 33:723-728, 1987
18. Soong R, Iacopetta BJ, Harvey JM, et al: Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer. Int J Cancer 74:642-647, 1997
19. Buttitta F, Marchetti A, Gadducci A, et al: p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: A molecular and immunohistochemical study. Br J Cancer 75:230-235, 1997
20. Carbone DP, Mitsudomi T, Chiba I, et al: p53 immunostaining positivity is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: A preliminary report of LCSG 871. Chest 106:377S-381S, 1994